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SUMMARY: bacteriocins are a distinct family of antimicrobial proteins postulated to porate 
bacterial membranes. However, direct experimental evidence of pore formation by these proteins 
is lacking. Here we report a multi-mode poration mechanism induced by four-helix bacteriocins, 
epidermicin NI01 and aureocin A53. Using a combination of crystallography, spectroscopy, 
bioassays and nanoscale imaging, we established that individual two-helix segments of 
epidermicin retain antibacterial activity but each of these segments adopts a particular poration 
mode. In the intact protein these segments act synergistically to balance out antibacterial and 
hemolytic activities. The study sets a precedent of multi-mode membrane disruption advancing 
the current understanding of structure-activity relationships in pore-forming proteins. 
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INTRODUCTION 
Host defense systems use pore-forming proteins to target pathogenic, host or aberrant cells 
(Parker and Feil, 2005). Bacteria secrete such proteins to access nutrients from the cells of their 
hosts or outcompete other bacteria living in the same environmental niches (Koehbach and Craik, 
2019; Cotter et al., 2013), while human leukocytes release pore-forming proteins to kill 
pathogens (Iacovach et al., 2010). The spread of antimicrobial resistance has intensified interest 
in molecules promoting the lysis of microbial membranes with an emphasis on host defense 
peptides as potential anti-infectives (Lazar et al, 2018). These peptides favour attack on microbial 
membranes and each tends to support one poration mechanism. The adoption of different 
mechanisms within the same sequence can be tuned by careful site-directed mutations (Pfeil et 
al., 2018). This modulation is possible because host defence peptides adopt relatively simple 
conformations in membranes. For example, only a single, short helix is required to elicit strong 
antimicrobial effects (Koehbach and Craik, 2019). Bacteria themselves produce more complex 
antibacterial agents, termed bacteriocins, which specialize in killing closely related bacterial 
strains (Acedo et al., 2018). The killing is proposed to occur through membrane poration, 
although experimental evidence for this conjecture has yet to be reported (Hechard and Sahl, 
2002).  
Bacteriocins can be divided into subclasses according to their structural organisation and size 
(Arnison et al., 2013), with the most recent subclass represented by a multi-helix bundle group. 
Bacteriocins of this subclass are small proteins comprising several α-helices packing into 
compact globular structures. Unlike other bacteriocins that have post-translational backbone, 
side-chain modifications or operate as tertiary complexes, proteins from this subclass are 
leaderless, single-chain and cysteine-free (Cotter et al., 2013; Cotter et al., 2005). 
Given that their structures are multi-helix folds, we reason that these proteins must induce multi-
mode mechanisms of membrane disruption, with each mode supported by a specific constituent 
of their structure. Herein we validate this hypothesis, reporting the direct observation of multi-
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mode membrane disruption by bacteriocins. We first determine a high-resolution crystal structure 
of epidermicin NI01 – a four-helix bacteriocin recently discovered in S. epidermis (Fig 1A) 
(Sandiford and Upton, 2012). We then synthesise individual constituents of this structure – two- 
and three-helix hairpins (Fig 1A and S1 in Supplemental Information) – characterise their 
biological and physical properties and compare them with those of the full-length epidermicin. 
Using atomic force microscopy, we demonstrate that each of helix-helix hairpins induces a 
distinct mode of membrane disruption in anionic phospholipid bilayers, whereas the intact protein 
combines all these modes into one synergetic mechanism which, to our knowledge, has not been 
observed before. We further demonstrate that this mechanism is not stereoselective as it is 
reproduced by the all-D version of NI01. We show that all tested structures are appreciably 
antimicrobial and that synergy between the different corresponding modes of membrane 
disruption balances out the antibacterial and hemolytic activities of the protein. Finally, we 
compare the disruption mechanisms of NI01 and another bacteriocin from the same fold group 
and find that the two mechanisms are strikingly similar sharing the same disruption modes. 
RESULTS 
NI01 folds into a four-helix bundle topology 
The X-ray structure of NI01 revealed that it folds into a compact, four-helix bundle in which two 
α-hairpins are linked through a kink (φ = -116º and ψ = 36º) in the central helix at H25 (Fig 
1B,C).   
The transition between α1 and α2 is mediated by a type III β-turn, and from α3 to α4 by G36, 
which forms a break at the end of the third helix (Fig 1B, Table S1). The hydrophobic residues of 
all helices are buried in the core of the bundle, which is characteristic of bacteriocins and 
essential to stabilise the fold in solution. Aromatic residues account for 20% of all residues in this 
protein but are not engaged in the core. Instead, their side chains are locked in paired π-π 
interactions that appear to act as staples between spatially adjacent helices. Five pairs are formed 
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to support inter-helical crossovers, only two of which are formed between sequential helices, 
namely the F4-W23 and W32-W41 pairs that link α1 and α2, and α3 and α4 helices, respectively 
(Fig 1D). Four of the pairs involve the C-terminal helix (α4) including all of the remaining pairs, 
H25-W50, Y18-Y43 and F10-F39 (Fig 1E). Given that this helix is stapled with each of the other 
three helices, it may function as a leader helix, which synchronizes the insertion of NI01 into 
membranes. The central α2 and α3 helices share no aromatic pairs between them, which is 
expected for helices oriented perpendicular to one another, and is common for leaderless 
bacteriocins (Lohans et al, 2013). Finally, the analysis of the structure by PISA (Krissinel and 
Henrick, 2007) did not indicate any significant contacts between protein monomers indicating 
that the protein is monomeric in aqueous solution (Fig 1B). 
NI01 folds cooperatively in solution and binds strongly to anionic membranes 
Each helix in NI01 is at least two helical turns in length, which is sufficient to support the 
cooperative folding of the protein. Circular dichroism (CD) spectroscopy confirmed helix 
formation by NI01 in aqueous buffers (Fig 2A), with sigmoidal unfolding curves giving a single 
transition midpoint (TM) of ~60 ºC (Fig 2B). 
Denaturation was also fully reversible: the spectra collected before and after the thermal 
denaturation were nearly identical (Fig S2A). The signal intensity at 202 nm, which remained the 
same during denaturation provided a clear isodichroic point indicating a two-state transition 
between helical and unfolded forms (Fig S2B). However, even at temperatures as high as 90 ºC 
NI01 retained helical content: the spectral Δε222/Δε208 ratios for all spectra recorded during the 
thermal transition were ≥1, as expected for helical bundles (Fig 2A and S2B) (Kelly et al., 2005). 
The observation is consistent with the fact that NI01 retains antimicrobial activity following 
exposure to elevated temperatures (80 ºC), as reported elsewhere (Arnison et al., 2013). The 
helical content of the protein in aqueous buffers was comparable to that in aqueous 2,2,2-
trifluoroethanol (TFE) (Fig S2C). Fluorinated alcohols promote intramolecular hydrogen bonding 
by excluding water from the solute and encompassing the polypeptide chain in a hydrophobic 
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“matrix” (Roccatano et al, 2002). Thus, the TFE-induced helix formation shows the extent to 
which an individual chain can fold into a helical state excluding supramolecular contributions. 
With no apparent changes at different TFE concentrations (Fig S2C), the helical content of NI01 
was also independent of peptide concentrations (Fig S2D). Collectively, the results are indicative 
of a highly stable protein that is fully folded in solution.  
Similar to other pore-forming proteins, which target bacteria, epidermicin is cationic having a net 
charge of +8 at neutral pH. In the crystal structure of NI01, polar side chains of each helix cluster 
on the exterior of the protein. In solution, the protein is a monodisperse particle of 2 nm in 
diameter exhibiting a high surface charge (ζ-potential of 20.8 ± 3.8 mV). These characteristics 
confer a high stability on the protein, allowing it to bind to anionic bacterial membranes as a 
monomer (Fig S3). Since NI01 is already folded in solution, CD spectroscopy could only reveal 
additive changes in helicity in membranes. As expected, the helical content for NI01 remained 
unchanged when it was measured in reconstituted phospholipid bilayers, which were constructed 
as unilamellar vesicles to mimic bacterial (anionic) and mammalian (zwitterionic) membranes 
(Fig S4A). Isothermal titration calorimetry (ITC) provided a more quantitative measure of 
protein-membrane interactions. Measured by titrating NI01 into anionic phospholipid 
membranes, binding isotherms revealed an exothermic process indicating enthalpy-driven ionic 
and hydrogen-bond interactions (Fig 2C). As protein-lipid ratios increased endothermic processes 
became more pronounced suggesting increasing contributions from hydrophobic interactions. 
This can be attributed to that the protein inserts deep into the hydrophobic interface of the bilayer 
(Fig 2C). The integrated heats fitted into a single site binding model gave a dissociation constant 
(KD) of 0.3 µM with a ΔG of -8.9 kcal/mol, both values consistent with the characteristics of 
membrane-targeting antibiotics and pore-forming proteins (Seelig, 2004; Khatib et al., 2016). The 
biphasic binding found during the titrations suggests a synergistic, multi-mode mechanism by 
which NI01 selectively targets bacterial membranes. No binding was detected in zwitterionic 
phospholipid membranes (Fig S4B), consistent with negligible levels of toxicity towards 
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mammalian cells lines (Sandiford and Upton, 2012) and erythrocytes (Table S2). It can thus be 
concluded that the protein selectively disrupts bacterial membranes by binding to their surfaces 
through charge interactions and then re-arrangement into pores or channels.  
NI01 induces a synergistic, multi-mode poration mechanism in anionic membranes 
We probed the mechanism of membrane disruption by visualizing the effect of NI01 on 
reconstituted membranes using time-resolved atomic force microscopy in aqueous buffers (in-
liquid AFM). The membranes of the same lipid composition used for the biophysical 
measurements in solution were deposited on mica surfaces as supported lipid bilayers (SLBs) 
(Rakowska et al., 2013). The resulting preparations yield flat (to within ≤0.1 nm) fluid-phase 
membranes that allow for accurate depth measurements of surface changes (Lin et al., 2006; 
Mingeot-Leclercq et al., 2008). Within minutes NI01 formed floral patterns on the SLBs. These 
patterns comprised roughly circular patches of thinned membranes radially propagating with 
petal-like lesions or pores (Fig 3A, S5A). Most patterns had three petals per patch (Fig 3B). The 
patches were ~2 nm in depth half-way through the bilayer, which is consistent with membrane 
thinning effects commonly observed for antimicrobial peptides (Pfeil et al., 2018). In contrast, the 
petal-like lesions extended all the way across the membrane (4 nm), i.e. were transmembrane 
pores (Fig 3C). The lesions were tapered at one end connecting with their respective patches, 
whereas the opposite end appeared as a growing circular pore merging with other pores (Figs 3D, 
E and S5A). Complementary to the ITC results, the AFM measurements showed that the 
bacteriocin was selective towards bacterial membranes. No changes could be detected in SLBs 
mimicking mammalian membranes, even at higher concentrations (Fig S5B).  
The patches of thinned membranes appear as contact regions from which NI01 radially diffuses 
into the lipid matrix. This scenario resembles mechanisms proposed for four- and five-helix 
protein toxins that insert into the upper leaflet of the bilayer where they arrange into pores 
(González et al, 2000; Michalek et al., 2013). Similarly, antimicrobial peptides accumulate in the 
upper leaflet causing the thinning of phospholipid bilayers (Heath et al., 2018). These studies 
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indicate that as more peptide binds to the bilayers thinning areas grow in size but not in depth, as 
also observed for NI01 (Fig 3E) (Mecke et al., 2005). This suggests that a portion of NI01 should 
specialize in binding to the upper leaflet and be plastic enough to orchestrate protein re-assembly 
into pores. β-hairpins and bent α-helices are common folding topologies that induce membrane 
thinning and exfoliation (Jang et al., 2006; Pyne et al., 2017). NI01 has three overlapping helical 
hairpins (Fig 1A). The two terminal hairpins have similar up-and-down topologies, in which 
individual helices are clearly separated by extended turns (Fig 1B). With the N- and C-terminal 
helices being twice the length of the central helices, the terminal hairpins have the capacity for 
transmembrane insertion. In contrast, the two central helices are arranged into an α-α corner via a 
kink at an obtuse angle, which constrains the helices into a more open hairpin conformation (Figs 
1B and S6). A boomerang-like shape of this hairpin could make it lie flat on membrane surfaces, 
favouring membrane thinning over transmembrane poration (Fig S6).  
Each mode of the mechanism is activated by a specific two-helix segment of NI01  
To gain more insight into these predictions, all three hairpins - α1α2, α2α3 and α3α4 (Fig 1A), 
were synthesised (Fig S1), characterised (Fig S7) and imaged by AFM on SLBs (Fig 4). The first 
two hairpins showed strikingly distinctive behaviours, each supporting exclusively one mode of 
the mechanism observed for NI01 (Fig 4).  
The first hairpin, α1α2, formed extended petal-like pores that ran parallel to each other without 
branching. The regions of thinned membranes that in NI01 served as branching points for the 
pores were absent in SLBs treated with α1α2. In contrast, membrane thinning was apparent in 
SLBs treated with α2α3, with no indication of transmembrane pores. Although the regions 
imaged for α2α3 were similar in size and morphology to those formed by NI01, the petal-like 
pores of α1α2 appeared thinner and more extended when compared to those of NI01 (Fig 4). 
Wide, circular pores were dominant in SLBs treated with α3α4, with membrane-thinning patches 
being also abundant, which together indicate that α3α4 induced a mixed mode of membrane 
disruption (Fig 4).  
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In these experiments, it is evident that membrane thinning patches occur only when α3 is present 
(Fig 4). Both α2α3 and α3α4 incorporate this helix and α3α4 is the only of the three hairpins that 
induces the two membrane rupture modes. Thus, α3 appears to support the interplay of rupture 
modes favoured by other helices. Further evidence for this was derived from the behaviour of the 
two terminal three-helix hairpins, which were also produced as individual sequences (Fig S1). 
The N-terminal hairpin (α1α2α3) should combine two rupture modes: transmembrane lesions of 
α1α2 and thinned patches of α2α3, but without the synergy characteristic of NI01 manifesting in 
the conserved combined patterns of thinned patches and petals. For the C-terminal three-helix 
hairpin (α2α3α4) membrane thinning is expected to dominate as the synergy was already lacking 
in α3α4, and α2α3 did not form transmembrane pores. Consistent with this reasoning, the two 
predicted modes of membrane disruption were evident for α1α2α3 (Fig S8A). Although circular 
transmembrane pores could be detected for α2α3α4, these were much smaller in size, which 
contrasted with the abundance of thinned membrane regions caused by this hairpin (Fig S8A). 
The two three-helix hairpins were partially folded in solution, indicating impaired cooperativity 
of folding in solution when compared to that of NI01 (Fig S8B). Comparable helical content in 
solution was recorded for α3α4, which is notable given that α1α2 and α2α3 were unfolded (Fig 
S7). As for these two-helix hairpins, helicity sharply increased upon membrane binding for the 
terminal hairpins (Figs S7, 8B) The results indicate that two- and three-helix hairpins containing 
α3 form membrane thinning patches, which emphasizes the mediatory role of this helix in 
supporting the interplay of the different modes of membrane disruption.  
The C-terminal helix, α4, is the only helix in NI01 interacting with all other helices via the 
aromatic pairs. It is also a part of α3α4, which is the only two-helix hairpin that folds in solution 
(Fig 1). In α2α3α4, α2 and α3 share no single aromatic pair between them. H25 is an exception in 
that it is located in the central turn connecting the two helices. The residue forms an aromatic pair 
with the terminal W50, which appears important for directing the insertion of α4. In addition, 
H25 is cationic, suggesting that it may bind to anionic lipids. Indeed, in both crystal forms H25 
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was observed to bind to SO2-4 (Fig S9). In antimicrobial peptides similar electrostatic interactions 
are formed between phosphate groups and cationic residues, which in NI01 are represented by 
lysine (Fig 1A). Consistent with the exothermic phase in the ITC measurements (Fig 2C), the 
residue displaces water from the phosphate and strongly binds to it. The formed interactions are 
strong enough for membrane binding and cooperative enough to allow different disruption modes 
to manifest in synergy, one distinctive, conserved mechanism.  
To test these conventions, all lysines were replaced with arginines in an all-arginine mutant of 
NI01, R-NI01 (Fig 1A). Unlike lysine, arginine is positively charged at all stages of membrane 
binding and insertion and traps more phosphate and water by providing five hydrogen-bond 
donors (Li et al., 2013). This difference manifests in a tighter binding to membrane surfaces, and, 
as shown elsewhere, limits protein insertion into the upper leaflet of the bilayer (Pyne et al., 
2017). Replacing H25 with arginine preserves the positive charge in the site, but also eliminates 
the H25-W50 pair compromising cooperativity in interactions between helices and the ability of 
α4 to insert. Indeed, this mutant produced exclusively thinning patches in the membranes, which 
were strikingly similar to those observed for α2α3 (Figs 4 and S10A). Furthermore, R-NI01 was 
50% less helical than NI01 (Fig S10B). The loss in helicity was restored upon binding to 
phospholipid membranes (Fig S10B). This behaviour was similar to that of the three-helix 
hairpins, which were considerably less helical in solution than NI01, but whose helical content 
increased in membranes (Fig S8B). These results indicate that this mutation had a detrimental 
effect on NI01 folding in solution and its multi-mode mechanism in membranes. 
The importance of these findings is two-fold. Firstly, the analysis of disruption mechanisms by 
individual hairpins confirm that NI01 exhibits a conserved, synergistic mechanism of membrane 
disruption. This is ensured by the cooperative folding of NI01 and tertiary contacts of its 
constituent helices. Each of these helices makes an important contribution to the complex pattern 
of this mechanism, but none of them is sufficient individually. Secondly, all hairpin derivatives 
disrupt bacterial mimetic membranes. This suggests that all of the hairpins are antimicrobial and 
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that their antimicrobial activities do not require a specific receptor to target bacteria, and 
therefore the antimicrobial activity of NI01 is not stereoselective. 
Synergy in the multi-mode mechanism determines the biological selectivity of the protein 
Considering the first point, NI01 and all of its derivatives exhibited comparable levels of 
antibacterial activity. Minimum inhibitory concentrations (MICs) were similar to those obtained 
for conventional antibiotics (Table S2). Noteworthy differences were observed in MICs for 
Gram-positive S. aureus and Gram-negative P. aeruginosa. NI01, α1α2 and α3α4 were equally 
effective against S. aureus and ineffective against P. aeruginosa. Intriguingly, α2α3 showed a 
reversed trend, which may be attributed to differences in the cell-wall structure of the bacteria. 
The peptidoglycan layer of Gram-positive cells is rich in anionic teichoic polymers, which might 
prevent α2α3 from reaching the cytoplasmic membrane (Yeaman and Yount, 2003). This 
proposition is supported by the observation that α2α3 remained largely unfolded in membranes 
and hence is subject to conformational fluctuations caused by binding to the teichoic polymers 
(Fig S7). All other hairpins and R-NI01 responded to membrane binding with sharp increases in 
helicity. Other Gram-positive bacteria, B. subtilis and M. luteus, proved to be susceptible to all of 
the NI01 derivatives used (Table S2). Peptidoglycans in these bacteria undergo continuous 
transformations from thick to thin layers, which makes their membranes more vulnerable to the 
attack by α2α3 (Tocheva et al., 2013; Vollmer, 2008). Consistent with the lack of activity against 
S. aureus, α2α3 failed to affect methicillin-resistant S. aureus (MRSA) strains. NI01 and the other 
two-helix hairpins maintained similar levels of activity against these pathogens when compared 
to those for the susceptible strain (Tables S2&3). The three-helix hairpins were less active against 
MRSA. Both these hairpins incorporate α2α3 that was inactive against any of the S. aureus 
strains tested. Therefore, the impact of thicker peptidoglycan layers of MRSA (García et al, 
2013), on their activity is expected to be greater (Tables S2& S3). Another notable trend was 
observed for Gram-negative bacteria. NI01 and its derivatives appeared to be active only against 
E. coli. Similar to peptidoglycan layers in Gram-positive bacteria, lipopolysaccharide (LPS) 
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layers represent a key virulence factor for Gram negative membranes. To probe this, two 
additional E. coli strains were tested: a short-chain LPS or rough strain, SBS363, and a smooth 
strain comprising full-length, mature O-chains, ML35 (Ebbensgaard et al., 2018). All derivatives 
were active against the rough, more susceptible type, but the smooth type was resistant to all two-
helix hairpins, except α1α2 (Table S3).  
Considering the second point, NI01 was re-made into an all-D form (Fig S1). The protein adopted 
helical conformations that quantitatively mirrored those of the wild-type all-L NI01 in both 
solution and membranes (Figs 2A and S4A). In bacterial membranes the all-D form revealed a 
strikingly similar pattern to that of the all-L form (Fig S11), and both epimeric forms exhibited 
comparable antibacterial activities across all bacteria and strains tested (Tables S2 & S3). Taken 
together the results of these biological tests confirmed the antibacterial properties of NI01, with 
stronger activities observed for the derivatives exhibiting transmembrane disruption modes.  
Bacteriocins, unlike host defence peptides or helminth defence molecules (Hammond et al., 
2019), do not originate from multicellular organisms. However, there can be a selective pressure 
on bacteria residing in human hosts to remain in a commensal state. Consequently, bacteriocins 
produced by these bacteria should be able to differentiate between bacterial and host cells. For 
therapeutic applications, this requirement extends to red blood cells, which are weakly anionic 
and can also be targeted by bacteriocins. In this regard, NI01 proved to be non-hemolytic in both 
L- and D-forms at concentrations equivalent to >100 x MICs against Gram positive strains. This 
result was striking as all other derivatives caused appreciable hemolysis, except α2α3, which 
showed no hemolytic activity even at high concentrations (>600 µg/mL). These findings suggest 
that this hairpin re-balances antibacterial and hemolytic activities of NI01 by effectively 
diminishing the impact of the terminal helices, which favour transmembrane poration. Hemolytic 
activities drastically increased for R-NI01 and other hairpins, all of which lack the synergy of 
inter-helix interactions characteristic for NI01. As a consequence, these derivatives were 
incapable to differentiate between bacterial and erythrocytic membranes. 
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Mechanistic similarities with other four-helix bacteriocins 
To this end, we have shown that NI01 exhibits a unique multi-mode mechanism of membrane 
disruption. To the best of our knowledge, this is also the first direct observation of bacteriocin-
induced poration, which prompts an obvious comparison with other bacteriocins.  
With this in mind, we performed a similar analysis for aureocin A53 (Fig 5A). This bacteriocin 
belongs to the same four-helix bundle group and its structure was recently solved by NMR 
spectroscopy (Fig 5B) (Acedo et al., 2016). As gauged by CD spectroscopy, the protein folded 
remarkably similar to that of NI01, with the two proteins having a nearly identical helical content 
(Fig 5C). A53 was as stable as NI01 with (TM) of ~54 ºC (Fig S12A), folded reversibly and 
independently of concentration (Fig S12B, C), and showed no changes at increasing TFE 
concentrations (Fig S12D). BLAST searches indicated a significant level of sequence homology 
between the two proteins (38% identity). The location and extent of turn regions and individual 
helices were also very similar, while hydrophobic, polar and aromatic residues were well 
conserved (Fig 5A). Outside of the identity regions the exact sequence compositions of NI01 and 
A53 are different. Despite that the observed structural similarities suggest that A53 might exhibit 
a similar mechanism of membrane disruption.  
AFM analyses of A53-treated anionic membranes showed disruption modes similar to those 
recorded for NI01: membrane thinning patches and transmembrane lesions and pores (Fig 5D). 
The patches were more extended than those for NI01. The petal-like lesions were 
morphologically similar to those of NI01, also ending with circular pores and grew out of the 
patches. Depth profiles for each mode were identical for the two bacteriocins (Figs 3C & 5E). 
Overall, the same characteristics of membrane disruption were evident for both proteins, which 
exhibited the same folding topology, sequence length and helical content. The variations in the 
mechanisms may be attributed to amino-acid permutations in helical and turn regions of the two 
proteins.    
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DISCUSSION 
Bacteriocins have long been recognized as highly specific antibiotics that bacteria develop to 
outcompete closely related strains. It has also been long thought that these small proteins act by 
porating bacterial membranes like other pore-forming toxins, some antibiotics and host-defense 
peptides (Hechard and Sahl, 2002) However, direct evidence for bacteriocin-promoted poration 
has been lacking, despite the fact that bacteriocins belong to a distinctive family of host defence 
molecules with a common protein fold (Cotter et al., 2013; Acedo et al., 2018; Hechard and Sahl, 
2002). Although several bacteriocin structures have been solved (Lohans et al., 2013; González et 
al., 2000; Acedo et al., 2016), the way their structural features specify antimicrobial mechanisms 
remains obscure. This study partially filled this gap by solving the fold of an archetypal 
bacteriocin, epidermicin NI01, and correlating it with a unique mechanism comprising several 
distinctive modes of membrane disruption, in contrast to alternative scenarios that assume one 
poration mode per membrane-disrupting agent. Furthermore, we experimentally demonstrated 
that it is the cooperativity of interactions between the structural constituents, helical hairpins, 
which orchestrates multiple modes into one synergistic process. For example, the central hairpin, 
α2α3, was found to have a direct and reciprocal impact on the terminal helices translating 
different disruption modes into one dynamic process. This mechanism is conserved, favors 
anionic membranes and is not stereoselective. Thinning patches and transmembrane petals tended 
to expand with time, whereas their morphology and depths did not change. This type of 
propagation is likely to occur at the expense of NI01 monomers oligomerizing on and in the lipid 
bilayers. Similarly, the transition from a patch to a lesion is likely to involve an oligomerization 
event. Existing models of membrane disruption by pore-forming proteins suggest that these 
proteins associate via their hydrophobic surfaces that become exposed as their cationic surfaces 
face anionic lipids (González et al., 2000; Michalek et al., 2013; Acedo et al., 2016). The models 
appear universal for proteins adopting four- and five-helix folds: acanthaporin produced by 
pathogenic amoebae, natural killer cell lysins and bacteriocins analogous to NI01 and A53 may 
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have different biological functions, but all share similar characteristics of high stability, surface 
charge and conserved folding and hence may disrupt membranes via similar mechanisms. It 
remains unclear however if membrane disruption involves a minimal, active oligomer which 
defines the size and dynamics of the forming pores, as was shown for single-helix antimicrobial 
peptides (Pyne et al., 2017).  
To sum up, our results revealed that the four-helix bundle organisation of bacteriocins is 
necessary to complete such a highly regulated and sophisticated mechanism. The fold itself 
encodes this decisively physical means of selective membrane attack that is likely to hold true for 
other single-chain bacteriocins. The behaviour of another four-helix bacteriocin, A53, supports 
this conclusion.   
LIMITATIONS OF THE STUDY 
The exact reason for this complex mechanism is unclear. One possibility is that four-helix folds 
may better adapt to overcome a wide range of resistant membranes. The subtlety with which 
constituent helices cooperate is what makes bacteriocins less susceptible to acquired antibacterial 
resistance. This contrasts with host-defense peptides and membrane-active antibiotics that rely on 
a single disruption mode and are less fit against emerging strategies of membrane resistance 
(Needham and Trent, 2013). Another question is whether a multi-mode membrane disruption 
constitutes a common hallmark of bacteriocins, which may distinguish these proteins from other 
pore-forming and antibacterial molecules. Extensive site-directed mutagenesis of bacteriocin 
sequences together with AFM analysis of their action on bacterial membranes may provide 
additional insights into the mechanism. These proposals merit further independent investigations. 
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MAIN FIGURE TITLES AND LEGENDS 
Figure 1. The structure of NI01. (A) Primary structure of NI01 and its derivatives – two-helix 
and three-helix hairpins, and an arginine mutant, R-NI01. Coloured staples indicate π-π 
interactions between aromatic residues of different helices, labelled α1-α4. Turns are underlined 
in the sequences. Arginine residues in R-NI01 are shown in blue. (B) Crystal structure of NI01. 
Ribbon representation from the N-terminus (blue) to the C-terminus (red). (C) Stick 
representation of the central kink linking two terminal hairpins at H25. (D) Two aromatic pairs, 
F4-W23 and W32-W41, between sequential helices: α1α2, and α3α4, respectively. (E) 
Remaining three aromatic pairs, all involving the C-terminal helix, H25-W50, Y18-Y43 and F10-
F39.  
Figure 2. NI01 folding. (A) CD spectra for NI01 (blue line) and its all-D form (20 µM protein) 
in 10 mM phosphate buffer (black line). (B) Thermal unfolding curve and its first derivative 
highlighting a single transition point (TM). (C) Isothermal titration calorimetry of NI01 (500 µM) 
binding to bacterial mimetic membranes. Heat absorbed (µcal/s) for each isotherm is plotted 
versus titration time (upper panel). Integrated heats (kcal/mol) are plotted versus protein-lipid 
molar ratios (lower panel), showing a curve fitting to a one-set binding model (black line).  
Figure 3. In liquid AFM imaging of reconstituted bacterial membranes incubated with 
NI01. (A) Topography of NI01-treated SLBs mimicking bacterial membranes (see Methods). (B) 
Higher magnification images of individual patches (brighter areas) with petal-like pores (darker 
areas) from (A). The images were taken within the first 10 min of incubation with NI01 (0.25 
µM). (C) Height profiles as measured along the highlighted lines in (A) and (B). (D) SLBs 
imaged at a low magnification, with the framed area imaged at a higher magnification (E) over 1 
hour to show growing pores and patches as highlighted by white arrows (from left to right). 
Colour scale bar is 15 nm. Length scale bars are 500 nm for (A) and (D), 100 nm for (B) and 200 
nm for (E).  
 22 
 
Figure 4. Membrane poration modes by two-helix hairpins. In liquid AFM topography 
images of SLBs mimicking bacterial membranes treated with two-helix hairpins derived from 
NI01. The images were taken within the first 5 min of incubation with each hairpin (0.25 µM). 
Height profiles are measured along the highlighted lines. Colour scale bar is 15 nm, length scale 
bars are 500 nm for the low magnification images (left) and 200 nm for the high magnification 
images (right). The two-helix hairpins are isolated segments of the reported crystal structure. 
Figure 5. Comparative behaviour of aureocin A53. (A) Amino-acid sequences of NI01 and 
A53. Identical amino acids are highlighted in cyan. (B) NMR solution structure of A53 
bacteriocin (PDB entry 2N8O rendered by PyMol) (Acedo et al., 2016). (C) CD spectra for NI01 
(dashed line) and A53 (black line) (20 µM protein) in 10 mM phosphate buffer. (D) Topography 
AFM images of anionic SLBs treated with A53 (0.25 µM). (E) A higher magnification image 
with height profiles measured along the highlighted lines. Colour and length scale bars are 15 nm 
and 500 nm (D) and 200 nm (E), respectively.  





• bacteriocins are antibacterial proteins believed to form pores in bacterial membranes 
• a multi-helix bacteriocin fold induces a multi-mode poration mechanism 
• each of two-helix segments of the bacteriocin adopts a particular poration mode 
• these segments act synergistically balancing out antibacterial and hemolytic activities 
